480TiP IMpower110: Phase III study on 1L atezolizumab...

Annals of Oncology 2016 / 12 Vol. 27; Iss. suppl_9

480TiP IMpower110: Phase III study on 1L atezolizumab (atezo) in PD-L1–selected chemotherapy (chemo)-naive NSCLC patients (pts)

De Marinis, F., Jassem, J., Spigel, D.R., Lam, S., Mocci, S., Sandler, A., Lopez-Chavez, A., Deng, Y., Giaccone, G., Herbst, R.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw594.044
Date:
December, 2016
File:
PDF, 75 KB
english, 2016
Conversion to is in progress
Conversion to is failed